quit readi pack bag
thesi updat complet mess today turn
worri balanc mck analyst day w/
wba report surfac wba print
mix fundament got focu turn
one quick pr amazon formal entri complex click
miss note argu pillpack
scale miniscul hard envis particularli relev
broadli forese futur wont matter frankli amazon
enter complex wall worri like scene
game throne investor petrifi share loss margin
compress forese futur realiti reflect
multipl compress stagnat number near term unlik
move alreadi well underway share nearli
intend go sharpen pencil speak industri expert
goal thought view come week
keep rate lower pt reflect less construct view
long term margin
program complet cours next year absent
retail pharmaci market share us grew bp y-o-i
highest report quarterli retail prescript market share
compani continu see challeng intern market
condit notabl retail compar retail sale retail
pharmaci boot uk lower
pharmaceut wholesal sale continu lag behind
estim anoth quarter due market condit certain
continent european countri off-set emerg market
continu next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
chang
rais
expect ep significantli impact
result broadli in-lin expect
compet sale hold guangzhou expect receiv final approv soon
 top prioriti deploy cash valu enhanc corpor develop invest
 absent larg expect complet program throughout next year
sell minor interest premis expect deal close juli
 receiv tax gain mm
medicar part sell season finish
 feel posit prospect
mm curtail gain prior year post-retir benefit
 open number clinic gainesvil store
 clinic perform well
 volum store continu increas steadili offer major portfolio
 new high profil custom sign fedex walgreen servic
 began trial number convers format
 end last week close store store optim program
 accept major plan
 partnership expand trial broaden primari care access wider popul custom
 skew medicar patient serv
 patient less like access cash-pay clinic
higher prescript volum central specialti despit pdp loss
busi grow msd led specialti
retail rx fill includ immun increas
market share bp vs last year
 saw gain prime unit off-set loss aet greater expect quarter
higher proport specialti quarter advers affect pharmaci bp
 mainli due central specialti
 sg improv consecut quarter
slowdown health well categori weaker cold flu allergi sale
sale behind estim due market condit certain continent european countri off-set emerg market
exclud gener procur margin cost inflationari pressur off-set favor impact higher sale
pillpack sale
realiz need chang level servic custom
follow compani offer servic physic pharmaci
continu invest technolog
model central specialti alliancerx commun model small commun specialti pharmaci close patient live
see increas number ldd limit distribut drug result global local relationship
partnership
dividend share repo
walgreen stat million except per share data fy end august usa pharmaci usa fe total cc sale total cc sale growth revenu margin growth revenu ep share net incom price-to-earnings premium/discount isi healthcar technolog distribut june
pt equat forward cy ep dcf tgr
downsid risk potenti on-line competit amazon erod front end comp margin us
pharmaci share continu reimburs pressur us eu hit ultim lead total margin compress
transact prove challeng increas volum revenu store appear futil lead poor return posit
independ retail us becom disadvantag vertic integr peer capabl take notabl share manag
unabl locat creativ transact leav balanc sheet underutil limit total oper growth beauti push
ultim becom distract momentum build manag must revisit costli rebuild store format
laboratori corp america hold
articl articl
time dissemin june et
analyst ross muken elizabeth anderson suzi yoon primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani issuer
part research analyst compens directli relat specif recommend view
